Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,515 | 56,878 | 51,865 | 58,441 | 52,593 |
| Marketable Securities | 77,234 | 98,965 | 113,256 | 130,851 | 145,519 |
| TOTAL | $137,709 | $160,169 | $169,631 | $194,051 | $206,009 |
| Non-Current Assets | |||||
| PPE Net | 53,715 | 56,649 | 59,532 | 62,141 | 65,284 |
| Investments And Advances | 213 | 3,228 | 21,239 | 31,346 | 47,130 |
| Intangibles | 34,200 | 34,200 | 34,200 | 34,200 | 38,527 |
| Other Non-Current Assets | 18,880 | 30,446 | 31,007 | 31,478 | 31,667 |
| TOTAL | $107,008 | $124,523 | $145,978 | $159,165 | $182,608 |
| Total Assets | $244,717 | $284,692 | $315,609 | $353,216 | $388,617 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 20 | 20 | N/A | 82 | 209 |
| Accounts payable and accrued liabilities | 2,617 | 3,208 | 3,573 | 3,075 | 2,598 |
| Accrued Expenses | 11,051 | 11,720 | 10,930 | 17,461 | 13,444 |
| Other current liabilities | 8,338 | N/A | N/A | N/A | N/A |
| TOTAL | $22,026 | $14,948 | $14,503 | $129,782 | $19,820 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 20 |
| Deferred Revenues | 0 | 0 | 0 | 109,164 | 3,569 |
| Other Non-Current Liabilities | 41,969 | 55,472 | 56,293 | 57,698 | 59,820 |
| TOTAL | $46,343 | $59,846 | $60,667 | $62,072 | $173,111 |
| Total Liabilities | $68,369 | $74,794 | $75,170 | $191,854 | $192,931 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 87,307 | 86,389 | 86,159 | 86,045 | 85,029 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -772,740 | -738,318 | -705,777 | -782,337 | -746,266 |
| Other shareholders' equity | 64 | 83 | 305 | 324 | 758 |
| TOTAL | $176,348 | $209,898 | $240,439 | $161,362 | $195,686 |
| Total Liabilities And Equity | $244,717 | $284,692 | $315,609 | $353,216 | $388,617 |